2021
Challenges in treatment of renal echinococcosis with gross hydatiduria and unsalvageable kidney: a case report
Shuaibi S, AlAshqar A, Alabdulhadi M, Al-Adsani W. Challenges in treatment of renal echinococcosis with gross hydatiduria and unsalvageable kidney: a case report. Journal Of Medical Case Reports 2021, 15: 487. PMID: 34587998, PMCID: PMC8479882, DOI: 10.1186/s13256-021-02992-2.Peer-Reviewed Case Reports and Technical NotesConceptsRenal echinococcosisExtensive renal involvementCase presentationThisFlank painRenal involvementPositive serologyParenchymal destructionConclusionThis caseRenal scintigraphyCase reportProper counselingTherapeutic approachesDual pharmacotherapyPatientsSurgeryHydatiduriaPharmacotherapyEchinococcosisRare occurrenceChallenges physiciansExposure historyScientific evidenceSatisfactory responseTreatmentPhysicians
2016
Tissue Transglutaminase Levels Are Not Sufficient to Diagnose Celiac Disease in North American Practices Without Intestinal Biopsies
Elitsur Y, Sigman T, Watkins R, Porto AF, Leonard Puppa EL, Foglio EJ, Preston DL. Tissue Transglutaminase Levels Are Not Sufficient to Diagnose Celiac Disease in North American Practices Without Intestinal Biopsies. Digestive Diseases And Sciences 2016, 62: 175-179. PMID: 27778203, DOI: 10.1007/s10620-016-4354-4.Peer-Reviewed Original ResearchMeSH KeywordsAdolescentAutoantibodiesBiopsyCeliac DiseaseChildChild, PreschoolDuodenumFemaleGTP-Binding ProteinsHumansImmunoglobulin AInfantIntestine, SmallMaleNorth AmericaPredictive Value of TestsProtein Glutamine gamma Glutamyltransferase 2Retrospective StudiesSensitivity and SpecificityTransglutaminasesConceptsCeliac diseasePositive predictive valuePredictive valueIntestinal biopsiesIntestinal histologyTissue transglutaminase levelsRoutine clinical practiceNegative predictive valueNorth American childrenCeliac childrenPositive serologySymptomatic childrenAmerican guidelinesClinical practiceDifferent clinicsHigh titersDiseaseBiopsyTransglutaminase levelsTitersTissue transglutaminaseChildrenSerologyHistologyPresent studyEmergent pacemaker placement in a patient with Lyme carditis-induced complete heart block and ventricular asystole
Brownstein AJ, Gautam S, Bhatt P, Nanna M. Emergent pacemaker placement in a patient with Lyme carditis-induced complete heart block and ventricular asystole. BMJ Case Reports 2016, 2016: bcr2016214474. PMID: 27207985, PMCID: PMC4885258, DOI: 10.1136/bcr-2016-214474.Peer-Reviewed Case Reports and Technical NotesConceptsComplete heart blockHeart blockVentricular asystoleSymptomatic complete heart blockPermanent pacemaker insertionEpisodes of syncopePacemaker placementPositive serologyAntibiotic therapyPacemaker insertionEmergency departmentKnown exposureLyme diseaseUnderlying rhythmAsystoleDiseaseEpisodesH time spanSyncopePatientsSerologyTherapySymptoms
2012
Pseudomonas aeruginosa serology and risk for re-isolation in the EPIC trial
Anstead M, Heltshe SL, Khan U, Barbieri JT, Langkamp M, Döring G, Dharia S, Gibson RL, Treggiari MM, Lymp J, Rosenfeld M, Ramsey B. Pseudomonas aeruginosa serology and risk for re-isolation in the EPIC trial. Journal Of Cystic Fibrosis 2012, 12: 147-153. PMID: 22944725, PMCID: PMC3696392, DOI: 10.1016/j.jcf.2012.08.001.Peer-Reviewed Original ResearchConceptsPulmonary exacerbationsCF patientsP. aeruginosa eradicationP. aeruginosa isolationCystic fibrosis patientsEarly P. aeruginosaBaseline seropositivityEPIC trialPositive serologyAntibiotic therapyChild TrialTreatment failurePrognostic valuePseudomonas infectionWeek 10Fibrosis patientsSerologyCulture resultsPatientsClinicians' effortsExacerbationSeropositivityP. aeruginosaRiskTrials
1996
Temporal Trends of Initial CD4 Cell Counts Following Human Immunodeficiency Virus Seroconversion in Italy, 1985–1992
Galai N, Lepri A, Vlahov D, Pezzotti P, Sinicco A, Rezza G, Study H. Temporal Trends of Initial CD4 Cell Counts Following Human Immunodeficiency Virus Seroconversion in Italy, 1985–1992. American Journal Of Epidemiology 1996, 143: 278-282. PMID: 8561162, DOI: 10.1093/oxfordjournals.aje.a008739.Peer-Reviewed Original ResearchConceptsCD4 cell measurementsInitial CD4 cell countHuman immunodeficiency virus (HIV) seroconversionCD4 cell countCell countCD4 cell count increaseItalian Seroconversion StudyLow CD4 countMonths of seroconversionYear of seroconversionCD4 cell levelsCell count increaseMedian lag timeCD4 countCD4 levelsHIV seroconversionPositive serologyNegative serologyHIV seroconvertersClinical centersRisk groupsSeroconversion StudySeroconversionMultivariate modelLag time
This site is protected by hCaptcha and its Privacy Policy and Terms of Service apply